Introduction
In an age where global health is front-of-mind, African scientists, led by researchers at the Institute of Genomics and Global Health (IGH) — formerly the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) — are quietly reshaping how the world detects, tracks, and understands infectious diseases. This breakthrough work is not only saving lives in Africa but also unlocking insights that could benefit the entire planet.
What Is IGH / ACEGID?
The Institute of Genomics and Global Health is based at Redeemer’s University in Ede, Nigeria, and was originally established in 2014 with funding from the World Bank to address Africa’s historical underrepresentation in genomic research.
It began as the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) and has since expanded into IGH, tackling infectious diseases, precision medicine, and emerging health threats across Africa and beyond.
Why This Is a Big Deal
For decades, Africa was mostly a data source for Western labs — samples shipped overseas for sequencing and interpretation. IGH flips that model on its head by doing world-class genomic research right in Africa, led by African scientists.
This includes:
- Rapid pathogen genomics — helping identify viruses like Ebola and Lassa fever in real-time
- On-site genome sequencing — now including full human genomes sequenced with cutting edge tech right in Nigeria
- Training the next generation of local scientists — creating capacity across the continent instead of draining talent overseas
Concrete Innovations & Impacts
1. Rapid Diagnostics
In previous outbreaks, African scientists at ACEGID developed rapid Ebola and Lassa fever tests capable of detecting infection in as little as 10 minutes — tests that were approved for emergency use by global institutions like WHO and the U.S. FDA.
These fast diagnostics can save lives by enabling early containment and treatment — especially where traditional lab infrastructure is sparse.
2. Local Genome Sequencing
Historically, Africa produced less than 2% of the world’s human genome data, despite holding enormous genetic diversity that the rest of the world still poorly understands. But IGH researchers are changing that by sequencing entire genomes locally using advanced platforms like Illumina’s NovaSeq, helping us understand disease susceptibility patterns that are unique to African populations.
Because African genomes are underrepresented in global databases — a major gap identified by genetic researchers worldwide — this work fills an essential blind spot in global health science.
Training & Capacity Building
Beyond just technologies and kits, IGH is training scientists who otherwise would have had few opportunities to work on world-leading genomic research on home soil. This capacity building is vital because it ensures that Africa won’t always have to rely on external labs for answers to its most pressing health challenges.
Why This Matters to the World
Global health security depends on equitable scientific development. When only a few countries control advanced tools like genome sequencers, blind spots emerge. Local outbreaks can become global pandemics — as we saw with COVID-19 — precisely because surveillance systems were uneven. IGH’s work helps close that gap by democratizing access to high-level scientific capability.
Conclusion: A Model for the Future
Africa is not just catching up in genomics — it’s leading in some of the most exciting applications, from rapid diagnostics to human genome sequencing. This progress is a powerful example of how science led by local expertise can serve local communities and global needs alike.
It’s a story the world needs to hear.
References & Sources
📌 https://ighresearch.org/en/service/the-african-centre-of-excellence-for-genomics-of-infectious-diseases-acegid/?
📌 https://ighresearch.org/en/?